151 related articles for article (PubMed ID: 1372753)
1. A single amino acid that determines the sensitivity of progesterone receptors to RU486.
Benhamou B; Garcia T; Lerouge T; Vergezac A; Gofflo D; Bigogne C; Chambon P; Gronemeyer H
Science; 1992 Jan; 255(5041):206-9. PubMed ID: 1372753
[TBL] [Abstract][Full Text] [Related]
2. Agonistic and antagonistic activities of RU486 on the functions of the human progesterone receptor.
Meyer ME; Pornon A; Ji JW; Bocquel MT; Chambon P; Gronemeyer H
EMBO J; 1990 Dec; 9(12):3923-32. PubMed ID: 2249658
[TBL] [Abstract][Full Text] [Related]
3. The molecular basis of RU486 resistance in the Tammar Wallaby, Macropus eugenii.
Lim-Tio SS; Keightley MC; Fletcher TP; Fuller PJ
Mol Cell Endocrinol; 1996 May; 119(2):169-74. PubMed ID: 8807636
[TBL] [Abstract][Full Text] [Related]
4. The mechanism of RU486 antagonism is dependent on the conformation of the carboxy-terminal tail of the human progesterone receptor.
Vegeto E; Allan GF; Schrader WT; Tsai MJ; McDonnell DP; O'Malley BW
Cell; 1992 May; 69(4):703-13. PubMed ID: 1586949
[TBL] [Abstract][Full Text] [Related]
5. Switching agonistic, antagonistic, and mixed transcriptional responses to 11 beta-substituted progestins by mutation of the progesterone receptor.
Garcia T; Benhamou B; Gofflo D; Vergezac A; Philibert D; Chambon P; Gronemeyer H
Mol Endocrinol; 1992 Dec; 6(12):2071-8. PubMed ID: 1337143
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of antihormone action.
Gronemeyer H; Benhamou B; Berry M; Bocquel MT; Gofflo D; Garcia T; Lerouge T; Metzger D; Meyer ME; Tora L
J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):217-21. PubMed ID: 1562505
[TBL] [Abstract][Full Text] [Related]
7. The partial agonist activity of antagonist-occupied steroid receptors is controlled by a novel hinge domain-binding coactivator L7/SPA and the corepressors N-CoR or SMRT.
Jackson TA; Richer JK; Bain DL; Takimoto GS; Tung L; Horwitz KB
Mol Endocrinol; 1997 Jun; 11(6):693-705. PubMed ID: 9171233
[TBL] [Abstract][Full Text] [Related]
8. Antagonist-occupied human progesterone receptors bound to DNA are functionally switched to transcriptional agonists by cAMP.
Sartorius CA; Tung L; Takimoto GS; Horwitz KB
J Biol Chem; 1993 May; 268(13):9262-6. PubMed ID: 8387487
[TBL] [Abstract][Full Text] [Related]
9. The steroid antagonist RU486 exerts different effects on the glucocorticoid and progesterone receptors.
Beck CA; Estes PA; Bona BJ; Muro-Cacho CA; Nordeen SK; Edwards DP
Endocrinology; 1993 Aug; 133(2):728-40. PubMed ID: 8344212
[TBL] [Abstract][Full Text] [Related]
10. Effects of the steroid antagonist RU486 on dimerization of the human progesterone receptor.
DeMarzo AM; Oñate SA; Nordeen SK; Edwards DP
Biochemistry; 1992 Nov; 31(43):10491-501. PubMed ID: 1420166
[TBL] [Abstract][Full Text] [Related]
11. The antiprogesterone RU486 stabilizes the heterooligomeric, non-DNA-binding, 8S-form of the rabbit uterus cytosol progesterone receptor.
Renoir JM; Radanyi C; Baulieu EE
Steroids; 1989; 53(1-2):1-20. PubMed ID: 2772964
[TBL] [Abstract][Full Text] [Related]
12. Distinct temporal and spatial activities of RU486 on progesterone receptor function in reproductive organs of ovariectomized mice.
Han SJ; Tsai SY; Tsai MJ; O'Malley BW
Endocrinology; 2007 May; 148(5):2471-86. PubMed ID: 17303655
[TBL] [Abstract][Full Text] [Related]
13. Characterization of R5020 and RU486 binding to progesterone receptor from calf uterus.
Hurd C; Moudgil VK
Biochemistry; 1988 May; 27(10):3618-23. PubMed ID: 3408715
[TBL] [Abstract][Full Text] [Related]
14. Progestin receptors: isoforms and antihormone action.
Gronemeyer H; Meyer ME; Bocquel MT; Kastner P; Turcotte B; Chambon P
J Steroid Biochem Mol Biol; 1991; 40(1-3):271-8. PubMed ID: 1958531
[TBL] [Abstract][Full Text] [Related]
15. RU486 exerts antiestrogenic activities through a novel progesterone receptor A form-mediated mechanism.
McDonnell DP; Goldman ME
J Biol Chem; 1994 Apr; 269(16):11945-9. PubMed ID: 8163495
[TBL] [Abstract][Full Text] [Related]
16. The antagonists RU486 and ZK98299 stimulate progesterone receptor binding to deoxyribonucleic acid in vitro and in vivo, but have distinct effects on receptor conformation.
Gass EK; Leonhardt SA; Nordeen SK; Edwards DP
Endocrinology; 1998 Apr; 139(4):1905-19. PubMed ID: 9528977
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of gene expression by steroid hormone receptors via a negative glucocorticoid response element: evidence for the involvement of DNA-binding and agonistic effects of the antiglucocorticoid/antiprogestin RU486.
Cairns C; Cairns W; Okret S
DNA Cell Biol; 1993 Oct; 12(8):695-702. PubMed ID: 8397827
[TBL] [Abstract][Full Text] [Related]
18. Coactivator/corepressor ratios modulate PR-mediated transcription by the selective receptor modulator RU486.
Liu Z; Auboeuf D; Wong J; Chen JD; Tsai SY; Tsai MJ; O'Malley BW
Proc Natl Acad Sci U S A; 2002 Jun; 99(12):7940-4. PubMed ID: 12048256
[TBL] [Abstract][Full Text] [Related]
19. Demonstration of mixed properties of RU486 in progesterone receptor (PR)-transfected MDA-MB-231 cells: a model for studying the functions of progesterone analogues.
Lin VC; Aw SE; Ng EH; Ng EH; Tan MG
Br J Cancer; 2001 Dec; 85(12):1978-86. PubMed ID: 11747343
[TBL] [Abstract][Full Text] [Related]
20. The progesterone antagonist RU486 acquires agonist activity upon stimulation of cAMP signaling pathways.
Beck CA; Weigel NL; Moyer ML; Nordeen SK; Edwards DP
Proc Natl Acad Sci U S A; 1993 May; 90(10):4441-5. PubMed ID: 8389450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
